Skip to content

A Phase 1 Study of BMS-986460 in Metastatic Castration-resistant Prostate Cancer

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-513987-24-00
Enrollment
22
Registered
2026-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic Castration-resistant Prostate Cancer

Interventions

None listed

Sponsors

Bristol-Myers Squibb Services Unlimited Company
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Jun 27, 2026